Glenmark Pharma Q4 results: Net profit jumps 36% to Rs 220 crore
New Delhi: Glenmark Pharmaceuticals on Friday posted a 36.28 per cent
increase in its consolidated net profit to Rs 220.3 crore for the fourth
quarter ended March 31, 2020.
The Mumbai-based drug firm had reported a net profit of Rs 161.66 crore for the corresponding period of 2018-19.
The company's consolidated revenue for the quarter rose 7.96 per cent to Rs 2,767.48 crore as against Rs 2,563.47 crore a year ago, Glenmark Pharmaceuticals said in a regulatory filing.
The Mumbai-based drug firm had reported a net profit of Rs 161.66 crore for the corresponding period of 2018-19.
The company's consolidated revenue for the quarter rose 7.96 per cent to Rs 2,767.48 crore as against Rs 2,563.47 crore a year ago, Glenmark Pharmaceuticals said in a regulatory filing.
For the financial year 2019-20, the company reported a consolidated net
profit of Rs 775.97 crore as against Rs 924.99 crore in 2018-19.
The company's consolidated revenue for 2019-20 rose to Rs 10,640.96 crore as against Rs 98,65.46 crore recording over the previous corresponding period.
The company's consolidated revenue for 2019-20 rose to Rs 10,640.96 crore as against Rs 98,65.46 crore recording over the previous corresponding period.
Comments
Post a Comment